C000021063 Holdings — VIP Health Care Portfolio
All 129 reported holdings of VIP Health Care Portfolio (C000021063) by percentage of net assets, from the fund's latest SEC N-PORT filing.
| Holding | % of net assets | Value (USD) |
|---|---|---|
| ELI LILLY and CO | 7.78% | $89.96M |
| Danaher Corp. | 6.42% | $74.29M |
| Thermo Fisher Scientific, Inc. | 5.03% | $58.16M |
| JOHNSON and JOHNSON | 4.57% | $52.83M |
| Fidelity Revere Street Trust | 4.49% | $51.93M |
| Unitedhealth Group, Inc. | 3.88% | $44.89M |
| Abbvie, Inc. | 2.79% | $32.21M |
| Ascendis Pharma A/s | 2.31% | $26.67M |
| Alnylam Pharmaceuticals, Inc. | 1.96% | $22.70M |
| MERCK and CO INC | 1.89% | $21.84M |
| Argenx SE | 1.77% | $20.45M |
| Gilead Sciences, Inc. | 1.75% | $20.21M |
| Boston Scientific Corp. | 1.70% | $19.63M |
| Natera, Inc. | 1.63% | $18.87M |
| Ucb SA | 1.63% | $18.80M |
| Agilent Technologies, Inc. | 1.53% | $17.68M |
| Moderna, Inc. | 1.51% | $17.51M |
| West Pharmaceutical Svcs, Inc. | 1.33% | $15.37M |
| Viatris, Inc. | 1.30% | $15.09M |
| Oruka Therapeutics, Inc. | 1.23% | $14.21M |
| Revolution Medicines, Inc. | 1.21% | $14.05M |
| Fidelity Revere Street Trust | 1.21% | $14.04M |
| Guardant Health, Inc. | 1.19% | $13.80M |
| Vaxcyte, Inc. | 1.17% | $13.55M |
| Cogent Biosciences, Inc. | 1.12% | $13.01M |
| Cvs Health Corp. | 1.12% | $12.93M |
| Veracyte, Inc. | 1.11% | $12.80M |
| Enliven Therapeutics, Inc. | 1.10% | $12.78M |
| 10x Genomics, Inc. | 1.07% | $12.41M |
| Repligen Corp. | 1.06% | $12.28M |
| Xenon Pharmaceuticals, Inc. | 1.04% | $12.07M |
| Caris Life Sciences, Inc. | 1.01% | $11.66M |
| Privia Health Group, Inc. | 1.00% | $11.58M |
| Spyre Therapeutics, Inc. | 0.98% | $11.36M |
| Bio Techne Corp. | 0.98% | $11.30M |
| Royalty Pharma PLC | 0.97% | $11.21M |
| Jazz Pharmaceuticals PLC | 0.96% | $11.08M |
| Kiniksa Pharmaceuticals International PLC | 0.94% | $10.88M |
| Legend Biotech Corp. | 0.91% | $10.47M |
| Kymera Therapeutics, Inc. | 0.85% | $9.86M |
| Bruker Corp. | 0.85% | $9.84M |
| Insmed, Inc. | 0.83% | $9.60M |
| Lifestance Health Group, Inc. | 0.80% | $9.23M |
| Praxis Precision Medicines Inc. | 0.75% | $8.70M |
| Roche Holding AG | 0.71% | $8.24M |
| Axsome Therapeutics, Inc. | 0.70% | $8.08M |
| Roivant Sciences Ltd. | 0.70% | $8.07M |
| Relay Therapeutics, Inc. | 0.61% | $7.03M |
| Brightspring Health Services, Inc. | 0.60% | $6.97M |
| Elevance Health, Inc. | 0.60% | $6.96M |
| Alignment Healthcare, Inc. | 0.59% | $6.79M |
| Crinetics Pharmaceuticals, Inc. | 0.57% | $6.59M |
| Cg Oncology, Inc. | 0.55% | $6.39M |
| Edwards Lifesciences Corp. | 0.54% | $6.24M |
| Sartorius Stedim Biotech | 0.54% | $6.22M |
| Cencora, Inc. | 0.53% | $6.17M |
| Biogen, Inc. | 0.52% | $6.05M |
| Travere Therapeutics, Inc. | 0.52% | $6.02M |
| Mineralys Therapeutics, Inc. | 0.51% | $5.88M |
| Disc Medicine, Inc. | 0.51% | $5.85M |
| Dianthus Therapeutics, Inc. | 0.50% | $5.81M |
| Mbx Biosciences, Inc. | 0.50% | $5.80M |
| Medline, Inc. | 0.49% | $5.72M |
| Heartflow, Inc. | 0.47% | $5.43M |
| Veradermics, Inc. | 0.45% | $5.16M |
| Viridian Therapeutics, Inc. | 0.44% | $5.14M |
| Structure Therapeutics, Inc. | 0.44% | $5.10M |
| Mirum Pharmaceuticals, Inc. | 0.43% | $5.01M |
| Twist Bioscience Corp. | 0.43% | $4.94M |
| Newamsterdam Pharma Company NV | 0.41% | $4.74M |
| Zenas Biopharma, Inc. | 0.41% | $4.70M |
| Amylyx Pharmaceuticals, Inc. | 0.40% | $4.67M |
| Pharvaris Bv | 0.38% | $4.43M |
| Scholar Rock Holding Corp. | 0.38% | $4.40M |
| Beone Medicines Ltd. | 0.37% | $4.27M |
| Kestra Medical Technologies, Inc. | 0.36% | $4.18M |
| Intuitive Surgical, Inc. | 0.36% | $4.18M |
| Alumis, Inc. | 0.35% | $4.11M |
| Viking Therapeutics, Inc. | 0.34% | $3.90M |
| Stoke Therapeutics, Inc. | 0.33% | $3.86M |
| Illumina, Inc. | 0.33% | $3.83M |
| Irhythm Technologies, Inc. | 0.33% | $3.81M |
| Olema Pharmaceuticals, Inc. | 0.31% | $3.57M |
| Jade Biosciences, Inc. | 0.30% | $3.41M |
| Trevi Therapeutics, Inc. | 0.29% | $3.36M |
| Cytomx Therapeutics, Inc. | 0.28% | $3.23M |
| Damora Therapeutics, Inc. | 0.27% | $3.07M |
| Immunocore Holdings PLC | 0.23% | $2.67M |
| Parabilis Medicines, Inc. | 0.23% | $2.65M |
| Gmr Solutions, Inc. | 0.21% | $2.47M |
| Kardium Corp. | 0.20% | $2.28M |
| Edgewise Therapeutics, Inc. | 0.19% | $2.19M |
| Cleerly, Inc. | 0.19% | $2.17M |
| Summit Therapeutics, Inc. | 0.18% | $2.11M |
| Element Biosciences, Inc. | 0.18% | $2.10M |
| Waystar Holding Corp. | 0.16% | $1.85M |
| First Tracks Biotherapeutics, Inc. | 0.14% | $1.61M |
| Tyra Biosciences, Inc. | 0.14% | $1.60M |
| Almar Biosciences, Inc. | 0.13% | $1.52M |
| Shoulder Innovations, Inc. | 0.13% | $1.49M |
| Medical Microinstruments, Inc. | 0.13% | $1.48M |
| Endeavor Biomedicines, Inc. | 0.12% | $1.36M |
| Contineum Therapeutics, Inc. | 0.11% | $1.31M |
| Galvanize Therapeutics | 0.11% | $1.29M |
| Insightec Ltd. | 0.11% | $1.26M |
| Insulet Corp. | 0.11% | $1.22M |
| Outset Medical, Inc. | 0.10% | $1.21M |
| Aledade, Inc. | 0.10% | $1.21M |
| Annexon, Inc. | 0.10% | $1.14M |
| Cellcentric Ltd. | 0.09% | $1.01M |
| Upstream Bio, Inc. | 0.09% | $1.00M |
| Zenas Biopharma, Inc. | 0.08% | $969.72K |
| Ocular Therapeutix, Inc. | 0.07% | $821.16K |
| Tubulis Gmbh | 0.07% | $768.31K |
| Perceptive Capital Solutions Corp. | 0.05% | $548.57K |
| Rallybio Corp. | 0.04% | $510.36K |
| Manus Bio, Inc. | 0.04% | $461.59K |
| Wugen, Inc. | 0.04% | $457.25K |
| Hemab Therapeutics Holdings, Inc. | 0.04% | $422.39K |
| Asimov, Inc. | 0.03% | $334.66K |
| Shoulder Innovations, Inc. | 0.03% | $326.51K |
| Immunome, Inc. | 0.03% | $289.67K |
| Dmed Biopharmaceutical Co. Ltd. | 0.02% | $271.07K |
| Saluda Medical, Inc. | 0.02% | $256.04K |
| Cyclerion Therapeutics, Inc. | 0.01% | $127.41K |
| Inmed Pharmaceuticals, Inc. | 0.01% | $82.78K |
| Candid Therapeutics | 0.01% | $58.97K |
| Elevatebio, LLC | 0.01% | $57.41K |
| Cyclerion Therapeutics, Inc. | 0.00% | $5.76K |
C000021063 overview: performance, fees, allocation and SEC filings